Zymeworks secures $250 million in royalty-backed financing from Royalty Pharma
Go back to Zymeworks secures $250 million in royalty-backed financing from Royalty Pharma| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 56.23 +1.54 (2.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.69 | 52 Week High | $3.48 | |||
| Open | $54.60 | 52 Week Low | $0.80 | |||
| Day High | $56.29 | P/E | N/A | |||
| Day Low | $54.60 | EPS | $-1.54 | |||
| Volume | 6,979,834 | |||||
| (NASDAQ: ZYME) | Delayed: 24.15 +0.38 (1.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.77 | 52 Week High | $ | |||
| Open | $23.75 | 52 Week Low | $ | |||
| Day High | $24.40 | P/E | N/A | |||
| Day Low | $23.52 | EPS | $ | |||
| Volume | 942,298 | |||||
